Yoshida, Takashi
Ri, Masaki http://orcid.org/0000-0002-9617-486X
Fujinami, Haruna
Oshima, Yoshiko
Tachita, Takuto
Marumo, Yoshiaki
Sasaki, Hirokazu
Kinoshita, Shiori
Totani, Haruhito
Narita, Tomoko
Masaki, Ayako
Ito, Asahi
Kusumoto, Shigeru
Ishida, Takashi
Komatsu, Hirokazu
Iida, Shinsuke
Funding for this research was provided by:
Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (16K07179, 16K09855)
National Cancer Center Research and Development Fund (26-A-4)
Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED (15ck0106077h0002)
Article History
Received: 27 December 2018
Revised: 15 May 2019
Accepted: 15 May 2019
First Online: 22 May 2019
Compliance with ethical standards
:
: MR received research funding from Celgene Co., Ltd. SI received research funding and declares Honoraria from Janssen Pharmaceutical K.K., and Celgene Co., Ltd. SI also received research funding from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Takeda Yakuhin Co., Ltd., and Ono Pharmaceutical Co., Ltd.